Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference38 articles.
1. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.;Mallika;Angiology,2007
2. Anti-inflammatory therapy for heart failure.;Matsumori;Curr Opin Pharmacol,2004
3. Angiotensin II and endothelin induce inflammation and thereby promote hypertension-induced end-organ damage.;Muller;Clin Nephrol,2003
4. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.;Verma;Circulation,2002
5. A novel bioactive 31-amino acid endothelin is a potent chemotactic peptide for human neutrophils and monocytes.;Cui;J Leukoc Biol,2001
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献